TrianglePUBLICATIONS · 24101038
Rituximab, methotrexate, procarbazine, and vincristine followed by consolidation reduced-dose whole-brain radiotherapy and cytarabine in newly diagnosed primary CNS lymphoma: final results and long-term outcome.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 2013 Nov 1
- First author
- Morris PG
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Morris PG
- type
- Author
- name
- Correa DD
- type
- Author
- name
- Yahalom J
- type
- Author
- name
- Raizer JJ
- type
- Author
- name
- Schiff D
- type
- Author
- name
- Grant B
- type
- Author
- name
- Grimm S
- type
- Author
- name
- Lai RK
- type
- Author
- name
- Reiner AS
- type
- Author
- name
- Panageas K
- type
- Author
- name
- Karimi S
- type
- Author
- name
- Curry R
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Morris PG
- type
- Author
- name
- Correa DD
- type
- Author
- name
- Yahalom J
- type
- Author
- name
- Raizer JJ
- type
- Author
- name
- Schiff D
- type
- Author
- name
- Grant B
- type
- Author
- name
- Grimm S
- type
- Author
- name
- Lai RK
- type
- Author
- name
- Reiner AS
- type
- Author
- name
- Panageas K
- type
- Author
- name
- Karimi S
- type
- Author
- name
- Curry R
- type
- Author
- bibliography ids
- nci-bib-27e6cdec809cbdde2d6ad123
- book metadata
- content sha256
- 36deab101cde37ad4e39e550c45e7d6459c882b70e239b9cae6b7a3e45e7c939
- document type
- citation
- dois
- 10.1200/JCO.2013.50.4910
- electronic publication date
- display
- 2013 Oct 7
- precision
- day
- year
- 2013
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:24101038
- immutable id
- pubmed:24101038@36deab101cde37ad4e39e550c45e7d6459c882b70e239b9cae6b7a3e45e7c939
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- 1527-7755
- issn print
- 0732-183X
- issue
- 31
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 3971-9
- volume
- 31
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 24101038
- provenance
- batch id
- 0a08f044391426feb8ef
- provider
- NCBI PubMed ESummary
- record sha256
- 3f33f84d65812d90f05a82d3b86360b7ac5c5e0ae9957f94649c7633604966ba
- response sha256
- d94e6242343e5962374663e5e5f0191e7b595329228d2e360db95a280e588409
- retrieved at
- 2026-09-09T23:46:57.614689+00:00
- publication date
- display
- 2013 Nov 1
- precision
- day
- year
- 2013
- publication types
- Clinical Trial, Phase II
- Journal Article
- Multicenter Study
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Rituximab, methotrexate, procarbazine, and vincristine followed by consolidation reduced-dose whole-brain radiotherapy and cytarabine in newly diagnosed primary CNS lymphoma: final results and long-term outcome.
Preserved source evidence · Not medical advice